Department of Radiology, Ernst Moritz Arndt University Greifswald, Greifswald, Germany.
Invest Radiol. 2011 Dec;46(12):783-9. doi: 10.1097/RLI.0b013e31822b124c.
To investigate three-echo T2*-corrected Dixon magnetic resonance imaging (MRI) for noninvasively estimating hepatic fat content (HFC) compared with biopsy.
One hundred patients (50 men, 50 women; mean age, 57.7±14.2 years) underwent clinically indicated liver core biopsy (102 valid tissue samples) and liver MRI 24 to 72 hours later. MRI was performed at 1.5T (Magnetom Avanto, Siemens Healthcare, Erlangen, Germany) using Dixon imaging with T2* correction (work in progress, WIP-432.rev.1, Siemens Healthcare). An ultrafast breath-hold three-echo 3D-gradient echo sequence with TR/TE1/TE2/TE3 of 11/2.4/4.8/9.6 milliseconds, and online calculation of T2*-corrected water images (signal intensities of water [SIW]), fat images (SIF), and fat content map (SIFAT=10×SIF/(SIW+SIF)) was used. SIs of the calculated fat content map (SIFAT) were verified using the histologically quantified HFC (HFC(path)). Spearman correlation for HFC(path) and SIFAT was calculated. Stage of fibrosis, hepatic iron content, and patterns of liver fat (macrovesicular, microvesicular, mixed) and their influence on predicting HFC by MRI were determined.
Correlation between SIFAT and HFC(path) was rspearman=0.89. Agreement between HFC predicted by MRI and HFC(path) calculated by nonlinear saturation-growth regression was rspearman=0.89. Kruskal-Wallis analysis revealed no significant difference for SIFAT across fibrosis grades (P=0.90) and liver iron content (P=0.76). Regarding the cellular architecture of liver fat, the microvesicular pattern showed lower mean ranks in SI than macrovesicular and mixed patterns (P=0.01).
T2*-corrected Dixon MRI is a noninvasive tool for estimating HFC, showing excellent correlation with liver biopsy without being limited by liver iron content and fibrosis/cirrhosis.
探讨三回波 T2*-校正 Dixon 磁共振成像(MRI)无创估计肝脂肪含量(HFC)与肝活检的比较。
100 例患者(男 50 例,女 50 例;平均年龄 57.7±14.2 岁)行临床指征性肝芯活检(102 例有效组织样本),并于 24 至 72 小时后行肝 MRI 检查。MRI 检查采用 1.5T(Siemens Healthcare,德国 Erlangen 的 Magnetom Avanto),采用 T2*-校正的 Dixon 成像(工作中,WIP-432.rev.1,Siemens Healthcare)。采用超快屏气三回波 3D-梯度回波序列,TR/TE1/TE2/TE3 为 11/2.4/4.8/9.6 毫秒,在线计算 T2*-校正水图像(水信号强度[S1W])、脂肪图像(SIF)和脂肪含量图(SIFAT=10×SIF/(SIW+SIF))。通过组织学量化的 HFC(HFC(path))验证计算的脂肪含量图(SIFAT)的信号强度。计算 HFC(path)和 SIFAT 的 Spearman 相关性。确定纤维化分期、肝铁含量以及肝脂肪的模式(大泡性、小泡性、混合性)及其对 MRI 预测 HFC 的影响。
SIFAT 与 HFC(path)之间的相关性为 rspearman=0.89。MRI 预测的 HFC 与非线性饱和增长回归计算的 HFC(path)之间的一致性为 rspearman=0.89。Kruskal-Wallis 分析显示,纤维化分级(P=0.90)和肝铁含量(P=0.76)之间的 SIFAT 无显著差异。关于肝脂肪的细胞结构,小泡性模式的 SI 均值低于大泡性和混合性模式(P=0.01)。
T2*-校正 Dixon MRI 是一种无创性工具,可用于估计 HFC,与肝活检具有极好的相关性,不受肝铁含量和纤维化/肝硬化的限制。